Single-shot antithymocyte globuline and daclizumab induction in simultaneous pancreas and kidney transplant recipient: Three-year results

Transplantation Proceedings

Volumn 37, Issue 4, 2005, Pages 1818-1820

  Schulz, T ^a   Flecken, M ^b   Kapischke, M ^b   Busing, M ^b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; DACLIZUMAB; FLUCONAZOLE; GANCICLOVIR; HYPERIMMUNE GLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VANCOMYCIN;

ABDOMINAL INFECTION; ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; EXPERIENCE; FEMALE; FEVER; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY ALLOGRAFT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RECURRENT INFECTION; RENAL GRAFT DYSFUNCTION; REPERFUSION; SURGICAL PATIENT; SURVIVAL RATE;

ADULT; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 20344394687     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.02.087     Document Type: Conference Paper

References (12)

1. A.C. Gruessner, D.E.R. Sutherland Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002 Clin Transpl 2002 41
2. D.E.R. Sutherland, A. Gruessner Pancreas transplantation in the United States as reported to the United Network of Organ Sharing (UNOS) and analyzed by the International Pancreas Transplant Registry J.M. Cecka P.I. Terasaki Clinical Transplants 1995 1995 UCLA Tissue Typing Laboratory Los Angeles, Calif 49
3. S. Rayhill, M. Heimes, A. Kirk Simultaneous pancreas-kidney transplantation recent experience at the University of Wisconsin Exp Clin Endocrinol Diabetes 104 1996 353
4. ® Transplantation 78 2004 339
5. T. Schulz, D. Martin, M. Heimes Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin Transplant Proc 30 1998 1533
6. M. Busing, D. Martin, T. Schulz Mycophenolat mofetil/tacrolimus/single- shot ATG versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation results of a prospective randomized single-center study Transplant Proc 30 1998 516
7. D.E.R. Sutherland, R.W. Gruessner, A. Gruessner Pancreas transplantation for treatment of diabetes mellitus World J Surg 25 2001 487
8. R.J. Corry, M.F. Egidi, R. Shapiro Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients Transplant Proc 30 1998 521
9. U.J. Hesse, R. Troisi, B. Jacobs A single center's clinical experience with quadruple immunosuppression including ATG or IL2 antibodies and mycophenolate mofetil in simultaneous pancreas-kidney transplants Clin Transplant 14 2000 340
10. K. Dette, G. Woeste, R. Schwarz Daclizumab and ATG versus ATG in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous [correction of simultaneus] pancreas-kidney transplantation analysis of early outcome Transplant Proc 34 2002 1909
11. M. Busing, U.T. Hopt, M. Quacken Morphological studies of graft pancreatitis following pancreas transplantation Br J Surg 80 1993 1170
12. P.F. Halloran, T.D. Batiuk, N.B. Goes Strategies to improve the immunologic management of organ transplants Clin Transplant 9 1995 227